21 Einträge gefunden

1. Therapiealgorithmen für das Mammakarzinom

   1. Blohmer, Jens-Uwe
   2. Schneeweiss, Andreas
   3. Bauerfeind, I.
   4. Fehm, T
   5. Muller , Volkmar
   6. Thomssen, Christoph
   7. Witzel, Isabell

   2021 - Forschungsinformationssystem des UKE
2. Update Breast Cancer 2021 Part 3 - Current Developments in the Treatment of Early Breast Cancer: Review and Assessment of Specialised Treatment Scenarios by an International Expert Panel

   1. Fehm, Tanja N
   2. Stickeler, Elmar
   3. Fasching, Peter A
   4. Janni, Wolfgang
   5. Kolberg-Liedtke, Cornelia
   6. Kolberg, Hans-Christian
   7. Lüftner, Diana

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Therapieoptionen beim hormonrezeptorpositiven, HER-2-negativen metastasierten Mammakarzinom

   1. Wöckel, Achim
   2. Bauerfeind, Ingo
   3. Fehm, Tanja
   4. Janni, Wolfgang
   5. Muller , Volkmar
   6. Thill, Marc
   7. Thomssen, Christoph

   2020 - Forschungsinformationssystem des UKE
4. Therapy Algorithms for the Diagnosis and Treatment of Patients with Early and Advanced Breast Cancer

   1. Schneeweiss, Andreas
   2. Bauerfeind, Ingo
   3. Fehm, Tanja
   4. Janni, Wolfgang
   5. Thomssen, Christoph
   6. Witzel, Isabell
   7. Wöckel, Achim

   2020 - Forschungsinformationssystem des UKE
5. International Consensus Conference for Advanced Breast Cancer, Lisbon 2019:ABC5 Consensus - Assessment by a German Group of Experts

   1. Thomssen, Christoph
   2. Lüftner, Diana
   3. Untch, Michael
   4. Haidinger, Renate
   5. Würstlein, Rachel
   6. Harbeck, Nadia
   7. Augustin, Doris

   2020 - Forschungsinformationssystem des UKE
6. ABC4-Konsensus: Bewertung durch eine deutsche Expertengruppe:4. Internationale Konsensuskonferenz zum fortgeschrittenen Mammakarzinom (ABC4), Lissabon, 04. 11. 2017

   1. Würstlein, Rachel
   2. Harbeck, Nadia
   3. Thomssen, Christoph
   4. Lüftner, Diana
   5. Augustin, Doris
   6. Briest, Susanne
   7. Ettl, Johannes

   2018 - Forschungsinformationssystem des UKE
7. Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians

   1. Gass, Paul
   2. Untch, Michael
   3. Müller, Volkmar
   4. Möbus, Volker
   5. Thomssen, Christoph
   6. Häberle, Lothar
   7. Erber, Ramona

   2018 - Forschungsinformationssystem des UKE
8. AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2018

   1. Liedtke, Cornelia
   2. Jackisch, Christian
   3. Thill, Marc
   4. Thomssen, Christoph
   5. Müller, Volkmar
   6. Janni, Wolfgang

   2018 - Forschungsinformationssystem des UKE
9. AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer:Update 2017

   1. Liedtke, Cornelia
   2. Thill, Marc
   3. Jackisch, Christian
   4. Thomssen, Christoph
   5. Müller, Volkmar
   6. Janni, Wolfgang

   2017 - Forschungsinformationssystem des UKE
10. German adjuvant intergroup node-positive study:a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer

    1. von Minckwitz, Gunter
    2. Möbus, Volker
    3. Schneeweiss, Andreas
    4. Huober, Jens
    5. Thomssen, Christoph
    6. Untch, Michael
    7. Jackisch, Christian

    2013 - Forschungsinformationssystem des UKE
11. AGO Recommendations for Diagnosis and Treatment of Patients with Early Breast Cancer:Update 2013

    1. Scharl, Anton
    2. Thomssen, Christoph
    3. Harbeck, Nadia
    4. Müller, Volkmar

    2013 - Forschungsinformationssystem des UKE
12. AGO Recommendations for Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2013

    1. Harbeck, Nadia
    2. Scharl, Anton
    3. Thomssen, Christoph
    4. Müller, Volkmar

    2013 - Forschungsinformationssystem des UKE
13. Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsies.

    1. Lebeau, Annette
    2. Turzynski, Andreas
    3. Braun, Susanne
    4. Behrhof, Wera
    5. Fleige, Barbara
    6. Schmitt, Wolfgang D
    7. Grob, Tobias

    2010 - Forschungsinformationssystem des UKE
14. Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer.

    1. Müller, Volkmar
    2. Thomssen, Christoph
    3. Schmidt, Marcus
    4. Glados, Manfred
    5. Jackisch, Christian
    6. Heilmann, Volker
    7. Hinke, Axel

    2010 - Forschungsinformationssystem des UKE - frei zugänglich
15. Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer.

    1. Konecny, Gottfried E
    2. Pauletti, Giovanni
    3. Untch, Michael
    4. Wang, He-Jing
    5. Möbus, Volker
    6. Kuhn, Walther
    7. Thomssen, Christoph

    2010 - Forschungsinformationssystem des UKE
16. Feasibility of measuring the prognostic factors uPA and PAI-1 in core needle biopsy breast cancer specimens.

    1. Thomssen, Christoph
    2. Harbeck, Nadia
    3. Dittmer, Juergen
    4. Abraha-Spaeth, Shanti R
    5. Papendick, Nancy
    6. Paradiso, Angelo
    7. Lisboa, Bjoern

    2009 - Forschungsinformationssystem des UKE
17. Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer.

    1. Untch, Michael
    2. Möbus, Volker
    3. Kuhn, Walther
    4. Muck, Bernd Rudolph
    5. Thomssen, Christoph
    6. Bauerfeind, Ingo
    7. Harbeck, Nadia

    2009 - Forschungsinformationssystem des UKE
18. A comparative study of tissue inhibitor of metalloproteinases-1 levels in plasma and tumour tissue from patients with primary breast cancer and in plasma from patients with metastatic breast cancer.

    1. Schrohl, Anne-Sofie
    2. Müller, Volkmar
    3. Christensen, Ib Jarle
    4. Pantel, Klaus
    5. Thomssen, Christoph
    6. Bruenner, Nils

    2008 - Forschungsinformationssystem des UKE
19. Cyclooxygenase-2 is a target gene of rho GDP dissociation inhibitor beta in breast cancer cells.

    1. Schunke, Dario
    2. Span, Paul
    3. Ronneburg, Henrike
    4. Dittmer, Angela
    5. Vetter, Martina
    6. Holzhausen, Hans-Jürgen
    7. Kantelhardt, Eva

    2007 - Forschungsinformationssystem des UKE
20. DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group.

    1. Maier, Sabine
    2. Nimmrich, Inko
    3. Koenig, Thomas
    4. Eppenberger-Castori, Serenella
    5. Bohlmann, Inga
    6. Paradiso, Angelo
    7. Spyratos, Frédérique

    2007 - Forschungsinformationssystem des UKE